249 related articles for article (PubMed ID: 35971800)
1. A paradigm shift in pharmacogenomics: From candidate polymorphisms to comprehensive sequencing.
Zhou Y; Koutsilieri S; Eliasson E; Lauschke VM
Basic Clin Pharmacol Toxicol; 2022 Dec; 131(6):452-464. PubMed ID: 35971800
[TBL] [Abstract][Full Text] [Related]
2. Prediction of drug response and adverse drug reactions: From twin studies to Next Generation Sequencing.
Lauschke VM; Ingelman-Sundberg M
Eur J Pharm Sci; 2019 Mar; 130():65-77. PubMed ID: 30684656
[TBL] [Abstract][Full Text] [Related]
3. Computational Tools to Assess the Functional Consequences of Rare and Noncoding Pharmacogenetic Variability.
Zhou Y; Lauschke VM
Clin Pharmacol Ther; 2021 Sep; 110(3):626-636. PubMed ID: 33998671
[TBL] [Abstract][Full Text] [Related]
4. Challenges Related to the Use of Next-Generation Sequencing for the Optimization of Drug Therapy.
Zhou Y; Lauschke VM
Handb Exp Pharmacol; 2023; 280():237-260. PubMed ID: 35792943
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenomics in the era of next generation sequencing - from byte to bedside.
Russell LE; Zhou Y; Almousa AA; Sodhi JK; Nwabufo CK; Lauschke VM
Drug Metab Rev; 2021 May; 53(2):253-278. PubMed ID: 33820459
[TBL] [Abstract][Full Text] [Related]
6. The Role of Next-Generation Sequencing in Pharmacogenetics and Pharmacogenomics.
Schwarz UI; Gulilat M; Kim RB
Cold Spring Harb Perspect Med; 2019 Feb; 9(2):. PubMed ID: 29844222
[TBL] [Abstract][Full Text] [Related]
7. Requirements for comprehensive pharmacogenetic genotyping platforms.
Lauschke VM; Ingelman-Sundberg M
Pharmacogenomics; 2016 Jun; 17(8):917-24. PubMed ID: 27248710
[TBL] [Abstract][Full Text] [Related]
8. Next-generation sequencing in pharmacogenomics - fit for clinical decision support?
Zhou Y; Lauschke VM
Expert Rev Clin Pharmacol; 2024 Mar; 17(3):213-223. PubMed ID: 38247431
[TBL] [Abstract][Full Text] [Related]
9. Next-generation sequencing of pharmacogenes: a critical analysis focusing on schizophrenia treatment.
Drögemöller BI; Wright GE; Niehaus DJ; Emsley R; Warnich L
Pharmacogenet Genomics; 2013 Dec; 23(12):666-74. PubMed ID: 24141736
[TBL] [Abstract][Full Text] [Related]
10. Challenges and opportunities associated with rare-variant pharmacogenomics.
Zhou Y; Tremmel R; Schaeffeler E; Schwab M; Lauschke VM
Trends Pharmacol Sci; 2022 Oct; 43(10):852-865. PubMed ID: 36008164
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive overview of the pharmacogenetic diversity in Ashkenazi Jews.
Zhou Y; Lauschke VM
J Med Genet; 2018 Sep; 55(9):617-627. PubMed ID: 29970487
[TBL] [Abstract][Full Text] [Related]
12. Novel copy-number variations in pharmacogenes contribute to interindividual differences in drug pharmacokinetics.
Santos M; Niemi M; Hiratsuka M; Kumondai M; Ingelman-Sundberg M; Lauschke VM; Rodríguez-Antona C
Genet Med; 2018 Jun; 20(6):622-629. PubMed ID: 29261188
[TBL] [Abstract][Full Text] [Related]
13. Targeted Next-Generation Sequencing for Comprehensive Genetic Profiling of Pharmacogenes.
Han SM; Park J; Lee JH; Lee SS; Kim H; Han H; Kim Y; Yi S; Cho JY; Jang IJ; Lee MG
Clin Pharmacol Ther; 2017 Mar; 101(3):396-405. PubMed ID: 27727443
[TBL] [Abstract][Full Text] [Related]
14. Variant discovery using next-generation sequencing and its future role in pharmacogenetics.
Russell LE; Schwarz UI
Pharmacogenomics; 2020 May; 21(7):471-486. PubMed ID: 32338137
[TBL] [Abstract][Full Text] [Related]
15. Exome-Wide Analysis of the DiscovEHR Cohort Reveals Novel Candidate Pharmacogenomic Variants for Clinical Pharmacogenomics.
Pandi MT; Williams MS; van der Spek P; Koromina M; Patrinos GP
Genes (Basel); 2020 May; 11(5):. PubMed ID: 32443490
[TBL] [Abstract][Full Text] [Related]
16. Integrating rare genetic variants into pharmacogenetic drug response predictions.
Ingelman-Sundberg M; Mkrtchian S; Zhou Y; Lauschke VM
Hum Genomics; 2018 May; 12(1):26. PubMed ID: 29793534
[TBL] [Abstract][Full Text] [Related]
17. APF2: an improved ensemble method for pharmacogenomic variant effect prediction.
Zhou Y; Pirmann S; Lauschke VM
Pharmacogenomics J; 2024 May; 24(3):17. PubMed ID: 38802404
[TBL] [Abstract][Full Text] [Related]
18. The genetic landscape of the human solute carrier (SLC) transporter superfamily.
Schaller L; Lauschke VM
Hum Genet; 2019 Dec; 138(11-12):1359-1377. PubMed ID: 31679053
[TBL] [Abstract][Full Text] [Related]
19. Potential of whole-genome sequencing-based pharmacogenetic profiling.
Caspar SM; Schneider T; Stoll P; Meienberg J; Matyas G
Pharmacogenomics; 2021 Feb; 22(3):177-190. PubMed ID: 33517770
[TBL] [Abstract][Full Text] [Related]
20. Personalized pharmacogenomics profiling using whole-genome sequencing.
Mizzi C; Peters B; Mitropoulou C; Mitropoulos K; Katsila T; Agarwal MR; van Schaik RH; Drmanac R; Borg J; Patrinos GP
Pharmacogenomics; 2014 Jun; 15(9):1223-34. PubMed ID: 25141897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
